Slabilax (sodium picosulfate) oral drops 7.5 mg/ml. 15 ml. vial

Description

Slabilax (sodium picosulfate) oral drops 7.5 mg/ml. 15 ml. vial

Composition

active substance: 1 ml (15 drops) contains 7.5 mg of sodium picosulfate;

Excipients: sodium benzoate (E 211), sorbitol (E 420), citric acid, sodium citrate, purified water.

Dosage form

Oral drops.

Main physical and chemical properties: clear solution from colorless to slightly greenish-yellowish color.

Pharmacotherapeutic group

Contact laxatives.
ATX code A06A B08.

Pharmacological properties

This drug belongs to a group of drugs used in gastroenterology as a laxative.
The main active ingredient of the drug is sodium picosulfate. This substance, which has laxative properties, belongs to the triarylmethane group.
Due to the metabolic processes that occur after the drug enters the body in the large intestine, due to its action, the absorption of fluids is slowed down, and the production of water and the release of electrolytes also increases.
As a result, stool softening occurs, which also increases their volume, and produces additional stimulation of peristalsis in the intestine.
Sodium picosulfate has a low absorption, little absorbed when it enters the intestine. Some partial absorption occurs only after the bacterial breakdown of the substance occurs. Absorption occurs when the drug enters the colon, then conjugation occurs and then the drug is excreted with the help of the intestine along with the secreted bile.

Indications

This drug Slabilax oral drops is used to treat:

• constipation;
• other conditions requiring easier bowel movement (bowel movements).

Contraindications

The drug in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or one of the auxiliary components.
Also contraindicated for:

• intestinal obstruction;
• bowel obstruction;
• severe dehydration;
• acute diseases of the gastrointestinal tract, including appendicitis;
• acute abdominal pain with nausea and vomiting.

When taken simultaneously with diuretics and adrenocorticosteroids, the risk of electrolyte imbalance may increase.
Should not be used in conjunction with antibiotics. they can weaken the effect of the laxative.
It is not used in pediatrics until the age of 4 years.

Application during pregnancy and lactation

This drug is undesirable for the treatment of pregnant women – only with serious indications for this.
If it is necessary to take the drug during breastfeeding, lactation is suspended.

Method of administration and dosage

The drug is intended for oral administration, the best time to take is in the evening.
Adults: 10-20 drops (corresponding to 5-10 mg of sodium picosulfate);
children over 4 years (only on prescription): 5-10 drops (corresponding to 2.5-5 mg of sodium picosulfate).
It is recommended to start with the lowest dose. The dose can be adjusted to the maximum recommended dose for regular bowel movements. The maximum daily dose of 20 drops (for adults) or 10 drops (for children 4 years of age and older) should not be exceeded.
Slabilax oral drops should be taken at night. After application of the drug, bowel movements occur in 10-12 hours. The drug can be used with or without liquid.
Slabilax should not be used daily or for a long period without establishing the cause of constipation.

Children

The drug should be used in children over 4 years of age only on prescription.

Overdose

Overdose cases have not been recorded at the moment.
Excessive intake of the drug causes:

• excessive liquefaction of stool, diarrhea;
• intestinal cramps;
• clinically significant loss of electrolytes, potassium;
• chronic diarrhea.

Symptomatic treatment is recommended – to flush the stomach, induce vomiting, ensure sufficient fluid intake into the body, take enterosorbents, antispasmodics, astringents.

Side effects

The drug is usually well tolerated. Side effects may occur in the form of:

• hypersensitivity reactions, including angioedema;
• rash, allergic urticaria, itching;
• abdominal cramps, diarrhea, flatulence;
• discomfort in the gastrointestinal tract.